{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:51:26Z","timestamp":1786323086831,"version":"build-2736575974"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00059-019-4833-4","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T14:24:48Z","timestamp":1562855088000},"page":"46-51","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Management of neoplastic pericardial disease","Behandlung neoplastisch bedingter Erkrankungen des Perikards"],"prefix":"10.1007","volume":"45","author":[{"given":"J.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7913-9464","authenticated-orcid":false,"given":"N.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,11]]},"reference":[{"issue":"3","key":"4833_CR1","first-page":"195","volume":"18","author":"K Mukai","year":"1988","unstructured":"Mukai\u00a0K, Shinkai\u00a0T, Tominaga\u00a0K, Shimosato\u00a0Y (1988) The incidence of secondary tumors of the heart and pericardium: a\u00a010-year study. Jpn J Clin Oncol 18(3):195\u2013201","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"4833_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11748-018-0912-3","volume":"66","author":"S Taguchi","year":"2018","unstructured":"Taguchi\u00a0S (2018) Comprehensive review of the epidemiology and treatments for malignant adult cardiac tumors. Gen Thorac Cardiovasc Surg 66(5):257\u2013262","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"2","key":"4833_CR3","first-page":"149","volume":"81","author":"L Gromadzi\u0144ski","year":"2013","unstructured":"Gromadzi\u0144ski\u00a0L, Przelaskowski\u00a0P, Januszko-Giergielewicz\u00a0B et al (2013) Cardiac tamponade as the first symptom of lung cancer. Pneumonol Alergol Pol 81(2):149\u2013153","journal-title":"Pneumonol Alergol Pol"},{"issue":"4","key":"4833_CR4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000348559","volume":"124","author":"I Burazor","year":"2013","unstructured":"Burazor\u00a0I, Imazio\u00a0M, Markel\u00a0G, Adler\u00a0Y (2013) Malignant pericardial effusion. Cardiology 124(4):224\u2013232","journal-title":"Cardiology"},{"issue":"20","key":"4833_CR5","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1136\/heartjnl-2015-307907","volume":"101","author":"SA Virk","year":"2015","unstructured":"Virk\u00a0SA, Chandrakumar\u00a0D, Villanueva\u00a0C, Wolfenden\u00a0H, Liou\u00a0K, Cao\u00a0C (2015) Systematic review of percutaneous interventions for malignant pericardial effusion. Heart 101(20):1619\u20131626","journal-title":"Heart"},{"issue":"16","key":"4833_CR6","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/eurheartj\/ehs372","volume":"34","author":"M Imazio","year":"2013","unstructured":"Imazio\u00a0M, Adler\u00a0Y (2013) Management of pericardial effusion. Eur Heart\u00a0J 34(16):1186\u20131197","journal-title":"Eur Heart J"},{"issue":"7","key":"4833_CR7","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/ca.22032","volume":"25","author":"M Loukas","year":"2012","unstructured":"Loukas\u00a0M, Walters\u00a0A, Boon\u00a0JM, Welch\u00a0TP, Meiring\u00a0JH, Abrahams\u00a0PH (2012) Pericardiocentesis: a\u00a0clinical anatomy review. Clin Anat 25(7):872\u2013881","journal-title":"Clin Anat"},{"issue":"11","key":"4833_CR8","first-page":"1251","volume":"15","author":"K Salem","year":"1999","unstructured":"Salem\u00a0K, Mulji\u00a0A, Lonn\u00a0E (1999) Echocardiographically guided pericardiocentesis\u2014the gold standard for the management of pericardial effusion and cardiac tamponade. Can J Cardiol 15(11):1251\u20131255","journal-title":"Can J Cardiol"},{"issue":"5","key":"4833_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/00063110-200610000-00002","volume":"13","author":"UM Kennedy","year":"2006","unstructured":"Kennedy\u00a0UM, Mahony\u00a0NJ (2006) A cadaveric study of complications associated with the subxiphoid and transthoracic approaches to emergency pericardiocentesis. Eur J Emerg Med 13(5):254\u2013259","journal-title":"Eur J Emerg Med"},{"issue":"6","key":"4833_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2459\/JCM.0000000000000649","volume":"19","author":"S Maggiolini","year":"2018","unstructured":"Maggiolini\u00a0S, De Carlini\u00a0CC, Imazio\u00a0M (2018) Evolution of the pericardiocentesis technique. J\u00a0Cardiovasc Med (hagerstown) 19(6):267\u2013273","journal-title":"J Cardiovasc Med (hagerstown)"},{"issue":"12","key":"4833_CR11","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1056\/NEJMvcm0907841","volume":"366","author":"MT Fitch","year":"2012","unstructured":"Fitch\u00a0MT, Nicks\u00a0BA, Pariyadath\u00a0M, McGinnis\u00a0HD, Manthey\u00a0DE (2012) Videos in clinical medicine. Emergency pericardiocentesis. N\u00a0Engl J Med 366(12):e17","journal-title":"N Engl J Med"},{"issue":"1","key":"4833_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13019-018-0774-x","volume":"13","author":"L Volk","year":"2018","unstructured":"Volk\u00a0L, Ikegami\u00a0H, Lee\u00a0LY, Lemaire\u00a0A (2018) Pericardial windows have limited diagnostic success. J\u00a0Cardiothorac Surg 13(1):87","journal-title":"J Cardiothorac Surg"},{"issue":"3","key":"4833_CR13","first-page":"1","volume":"7","author":"DH Spodick","year":"1976","unstructured":"Spodick\u00a0DH (1976) The pericardium: structure, function, and disease spectrum. Cardiovasc Clin 7(3):1\u201310","journal-title":"Cardiovasc Clin"},{"issue":"2","key":"4833_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0003-4975(98)01192-8","volume":"67","author":"KB Allen","year":"1999","unstructured":"Allen\u00a0KB, Faber\u00a0LP, Warren\u00a0WH, Shaar\u00a0CJ (1999) Pericardial effusion: subxiphoid pericardiostomy versus percutaneous catheter drainage. Ann Thorac Surg 67(2):437\u2013440","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"4833_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jtcvs.2010.09.015","volume":"141","author":"PL Wagner","year":"2011","unstructured":"Wagner\u00a0PL, McAleer\u00a0E, Stillwell\u00a0E et\u00a0al (2011) Pericardial effusions in the cancer population: prognostic factors after pericardial window and the impact of paradoxical hemodynamic instability. J\u00a0Thorac Cardiovasc Surg 141(1):34\u201338","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"10","key":"4833_CR16","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jacc.2015.06.1332","volume":"66","author":"HD El","year":"2015","unstructured":"El\u00a0HD, Iliescu\u00a0C, Yusuf\u00a0SW et\u00a0al (2015) Outcomes of cancer patients undergoing percutaneous pericardiocentesis for pericardial effusion. J\u00a0Am Coll Cardiol 66(10):1119\u20131128","journal-title":"J Am Coll Cardiol"},{"key":"4833_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12872-016-0316-1","volume":"16","author":"BH Jong","year":"2016","unstructured":"Jong\u00a0BH, Wei\u00a0CC, Shyu\u00a0KG (2016) Improved hyponatremia after pericardial drainage in patients suffering from cardiac tamponade. BMC Cardiovasc Disord 16:135","journal-title":"BMC Cardiovasc Disord"},{"issue":"42","key":"4833_CR18","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Y Adler","year":"2015","unstructured":"Adler\u00a0Y, Charron\u00a0P, Imazio\u00a0M et al (2015) 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart\u00a0J 36(42):2921\u20132964","journal-title":"Eur Heart J"},{"issue":"6","key":"4833_CR19","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/icvts\/ivu267","volume":"19","author":"GM Jama","year":"2014","unstructured":"Jama\u00a0GM, Scarci\u00a0M, Bowden\u00a0J, Marciniak\u00a0SJ (2014) Palliative treatment for symptomatic malignant pericardial effusion. Interact Cardiovasc Thorac Surg 19(6):1019\u20131026","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"6","key":"4833_CR20","first-page":"906","volume":"35","author":"Y Hosomi","year":"2008","unstructured":"Hosomi\u00a0Y, Ohkuma\u00a0Y, Shibuya\u00a0M (2008) Treatment of malignant pericardial effusion. Gan To Kagaku Ryoho 35(6):906\u2013909","journal-title":"Gan To Kagaku Ryoho"},{"issue":"8","key":"4833_CR21","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/1010-7940(91)90189-Q","volume":"5","author":"PS Olsen","year":"1991","unstructured":"Olsen\u00a0PS, S\u00f8rensen\u00a0C, Andersen\u00a0HO (1991) Surgical treatment of large pericardial effusions. Etiology and long-term survival. Eur J Cardiothorac Surg 5(8):430\u2013432","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"4833_CR22","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1308\/003588415X14181254789925","volume":"97","author":"E Altman","year":"2015","unstructured":"Altman\u00a0E, Rutsky\u00a0O, Shturman\u00a0A, Yampolsky\u00a0Y, Atar\u00a0S (2015) Anterior parasternal approach for creation of a\u00a0pericardial window. Ann R Coll Surg Engl 97(5):375\u2013378","journal-title":"Ann R Coll Surg Engl"},{"issue":"10","key":"4833_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11886-018-1040-5","volume":"20","author":"R Schusler","year":"2018","unstructured":"Schusler\u00a0R, Meyerson\u00a0SL (2018) Pericardial disease associated with malignancy. Curr Cardiol Rep 20(10):92","journal-title":"Curr Cardiol Rep"},{"issue":"2","key":"4833_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1510\/icvts.2010.243725","volume":"12","author":"MI Muhammad","year":"2011","unstructured":"Muhammad\u00a0MI (2011) The pericardial window: is a\u00a0video-assisted thoracoscopy approach better than a\u00a0surgical approach. Interact Cardiovasc Thorac Surg 12(2):174\u2013178","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"5","key":"4833_CR25","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.amjcard.2017.06.003","volume":"120","author":"SE Horr","year":"2017","unstructured":"Horr\u00a0SE, Mentias\u00a0A, Houghtaling\u00a0PL et\u00a0al (2017) Comparison of outcomes of pericardiocentesis versus surgical pericardial window in patients requiring drainage of pericardial effusions. Am J Cardiol 120(5):883\u2013890","journal-title":"Am J Cardiol"},{"issue":"1","key":"4833_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0019-4832(12)60018-2","volume":"64","author":"A Puri","year":"2012","unstructured":"Puri\u00a0A, Agarwal\u00a0N, Dwivedi\u00a0SK, Narain\u00a0VS (2012) Percutaneous balloon pericardiotomy for the treatment of recurrent malignant pericardial effusion. Indian Heart\u00a0J 64(1):88\u201389","journal-title":"Indian Heart J"},{"issue":"1","key":"4833_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0300-8932(02)76549-4","volume":"55","author":"DALF Navarro","year":"2002","unstructured":"Navarro\u00a0DALF, C\u00f3rdoba\u00a0PM, Orejas\u00a0OM, L\u00f3pez\u00a0FT, Mohandes\u00a0M, I\u00f1\u00edguez\u00a0RA (2002) Percutaneous balloon pericardiotomy in patients with recurrent pericardial effusion. Rev Esp Cardiol 55(1):25\u201328","journal-title":"Rev Esp Cardiol"},{"issue":"5","key":"4833_CR28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/joic.12221","volume":"28","author":"R Bhardwaj","year":"2015","unstructured":"Bhardwaj\u00a0R, Gharib\u00a0W, Gharib\u00a0W, Warden\u00a0B, Jain\u00a0A (2015) Evaluation of safety and feasibility of percutaneous balloon pericardiotomy in hemodynamically significant pericardial effusion (review of 10-years experience in single center). J\u00a0Interv Cardiol 28(5):409\u2013414","journal-title":"J Interv Cardiol"},{"issue":"5S1","key":"4833_CR29","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.carrev.2017.03.029","volume":"18","author":"FJ Irazusta","year":"2017","unstructured":"Irazusta\u00a0FJ, Jim\u00e9nez-Valero\u00a0S, Gemma\u00a0D et al (2017) Percutaneous balloon pericardiotomy: treatment of choice in patients with advanced oncological disease and severe pericardial effusion. Cardiovasc Revasc Med 18(5S1):S14\u2013S17","journal-title":"Cardiovasc Revasc Med"},{"issue":"4","key":"4833_CR30","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.5830\/CVJA-2013-019","volume":"24","author":"B Kilicaslan","year":"2013","unstructured":"Kilicaslan\u00a0B, Susam\u00a0I, Dursun\u00a0H, Ekmekci\u00a0C, Aydin\u00a0M, Ozdogan\u00a0O (2013) Percutaneous balloon pericardiotomy using the Inoue balloon for patients with recurrent pericardial tamponade. Cardiovasc J Afr 24(4):e10\u20132","journal-title":"Cardiovasc J Afr"},{"issue":"5","key":"4833_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.recesp.2012.09.018","volume":"66","author":"J Ruiz-Garc\u00eda","year":"2013","unstructured":"Ruiz-Garc\u00eda\u00a0J, Jim\u00e9nez-Valero\u00a0S, Moreno\u00a0R et al (2013) Percutaneous balloon pericardiotomy as the initial and definitive treatment for malignant pericardial effusion. Rev Esp Cardiol 66(5):357\u2013363","journal-title":"Rev Esp Cardiol"},{"issue":"6","key":"4833_CR32","first-page":"298","volume":"51","author":"JR Osuch","year":"1985","unstructured":"Osuch\u00a0JR, Khandekar\u00a0JD, Fry\u00a0WA (1985) Emergency subxiphoid pericardial decompression for malignant pericardial effusion. Am Surg 51(6):298\u2013300","journal-title":"Am Surg"},{"issue":"1","key":"4833_CR33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13019-016-0488-x","volume":"11","author":"I Sakanoue","year":"2016","unstructured":"Sakanoue\u00a0I, Hamakawa\u00a0H, Okubo\u00a0Y et al (2016) Efficacy and safety of thoracoscopic pericardial window in patients with pericardial effusions: a\u00a0single-center case series. J\u00a0Cardiothorac Surg 11(1):92","journal-title":"J Cardiothorac Surg"},{"issue":"8","key":"4833_CR34","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/echo.13229","volume":"33","author":"AJ Han","year":"2016","unstructured":"Han\u00a0AJ, Slomka\u00a0T, Mehrotra\u00a0A, Murillo\u00a0LC, Alsafwah\u00a0SF, Khouzam\u00a0RN (2016) Paradoxical Hemodynamic instability after pericardial window. Echocardiography 33(8):1251\u20131252","journal-title":"Echocardiography"},{"issue":"3","key":"4833_CR35","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1053\/j.jvca.2018.04.009","volume":"33","author":"J Chung","year":"2018","unstructured":"Chung\u00a0J, Ocken\u00a0L, Wolo\u00a0E, Herman\u00a0CR, Goldhammer\u00a0JE (2018) Acute right ventricular failure after surgical drainage of pericardial tamponade: a case report of pericardial decompression syndrome and review of the literature. J\u00a0Cardiothorac Vasc Anesth 33(3):768\u2013771","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"4833_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/jso.25283","volume":"119","author":"T Kazantzis","year":"2019","unstructured":"Kazantzis\u00a0T, Bibas\u00a0BJ, Dela-Vega\u00a0AJ et al (2019) Predictors of hospital discharge in cancer patients with pericardial effusion undergoing surgical pericardial drainage. J\u00a0Surg Oncol 119(1):143\u2013147","journal-title":"J Surg Oncol"},{"issue":"Suppl","key":"4833_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.addr.2012.09.011","volume":"64","author":"RK Jain","year":"2012","unstructured":"Jain\u00a0RK (2012) Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev 64(Suppl):353\u2013365. https:\/\/doi.org\/10.1016\/j.addr.2012.09.011","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"4833_CR38","first-page":"287","volume":"3","author":"AF Hanafy","year":"2009","unstructured":"Hanafy\u00a0AF, El-Egaky\u00a0AM, Mortada\u00a0SA, Molokhia\u00a0AM (2009) Development of implants for sustained release of 5\u2011fluorouracil using low molecular weight biodegradable polymers. Drug Discov Ther 3(6):287\u2013295","journal-title":"Drug Discov Ther"},{"issue":"4","key":"4833_CR39","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/sj.bjc.6605108","volume":"101","author":"C Lestuzzi","year":"2009","unstructured":"Lestuzzi\u00a0C, Lafaras\u00a0C, Bearz\u00a0A et\u00a0al (2009) Malignant pericardial effusion: sclerotherapy or local chemotherapy. Br J Cancer 101(4):734\u2013735 (author reply 736\u20137)","journal-title":"Br J Cancer"},{"issue":"7","key":"4833_CR40","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1021\/acs.bioconjchem.5b00046","volume":"26","author":"JM Coburn","year":"2015","unstructured":"Coburn\u00a0JM, Kaplan\u00a0DL (2015) Engineering biomaterial-drug conjugates for local and sustained chemotherapeutic delivery. Bioconjug Chem 26(7):1212\u20131223","journal-title":"Bioconjug Chem"},{"key":"4833_CR41","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.colsurfb.2018.11.018","volume":"174","author":"P Sahu","year":"2018","unstructured":"Sahu\u00a0P, Kashaw\u00a0SK, Sau\u00a0S et al (2018) pH responsive 5\u2011fluorouracil loaded biocompatible nanogels for topical chemotherapy of aggressive melanoma. Colloids Surf B Biointerfaces 174:232\u2013245","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"42","key":"4833_CR42","first-page":"2874","volume":"36","author":"P Charron","year":"2015","unstructured":"Charron\u00a0P, Adler\u00a0Y (2015) \u201cTen Commandments\u201d of 2015 ESC Guidelines for diagnosis and management of pericardial diseases. Eur Heart\u00a0J 36(42):2874","journal-title":"Eur Heart J"},{"issue":"7","key":"4833_CR43","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11748-013-0302-9","volume":"63","author":"Y Hikosaka","year":"2015","unstructured":"Hikosaka\u00a0Y, Yano\u00a0M, Otsuka\u00a0S et al (2015) Post-irradiation constrictive pericarditis following thymoma treatment: a\u00a0report of two cases. Gen Thorac Cardiovasc Surg 63(7):413\u2013415","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"3","key":"4833_CR44","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3322\/canjclin.41.3.166","volume":"41","author":"OI Olopade","year":"1991","unstructured":"Olopade\u00a0OI, Ultmann\u00a0JE (1991) Malignant effusions. CA Cancer J Clin 41(3):166\u2013179","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"4833_CR45","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1148\/rg.336125005","volume":"33","author":"CM Walker","year":"2013","unstructured":"Walker\u00a0CM, Salda\u00f1a\u00a0DA, Gladish\u00a0GW et\u00a0al (2013) Cardiac complications of oncologic therapy. Radiographics 33(6):1801\u20131815","journal-title":"Radiographics"},{"issue":"8","key":"4833_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0147-0272(81)80012-8","volume":"5","author":"A Memon","year":"1981","unstructured":"Memon\u00a0A, Zawadzki\u00a0ZA (1981) Malignant effusions: diagnostic evaluation and therapeutic strategy. Curr Probl Cancer 5(8):1\u201330","journal-title":"Curr Probl Cancer"},{"key":"4833_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/nano8020075","author":"KC Zatta","year":"2018","unstructured":"Zatta\u00a0KC, Frank\u00a0LA, Reolon\u00a0LA et al (2018) An Inhalable powder formulation based on micro- and nanoparticles containing 5\u2011Fluorouracil for the treatment of metastatic melanoma. Nanomaterials (Basel). https:\/\/doi.org\/10.3390\/nano8020075","journal-title":"Nanomaterials (Basel)"},{"key":"4833_CR48","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.colsurfb.2018.11.088","volume":"175","author":"X Wu","year":"2018","unstructured":"Wu\u00a0X, Liu\u00a0J, Yang\u00a0L, Wang\u00a0F (2018) Photothermally controlled drug release system with high dose loading for synergistic chemo-photothermal therapy of multidrug resistance cancer. Colloids Surf B Biointerfaces 175:239\u2013247","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"10","key":"4833_CR49","doi-asserted-by":"publisher","first-page":"12824","DOI":"10.1021\/acsomega.8b01737","volume":"3","author":"A Upadhyay","year":"2018","unstructured":"Upadhyay\u00a0A, Yagnik\u00a0B, Desai\u00a0P, Dalvi\u00a0SV (2018) Microbubble-mediated enhanced delivery of curcumin to cervical cancer cells. ACS Omega 3(10):12824\u201312831","journal-title":"ACS Omega"},{"key":"4833_CR50","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrd4591","volume":"14","author":"KM Mahoney","year":"2015","unstructured":"Mahoney\u00a0KM, Rennert\u00a0PD, Freeman\u00a0GJ (2015) Combination cancer immunotherapy and new immunomodulatory targets. Nat Rev Drug Discov 14:561","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"4833_CR51","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma\u00a0P, Hu-Lieskovan\u00a0S, Wargo\u00a0JA, Ribas\u00a0A (2017) Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168(4):707\u2013723","journal-title":"Cell"},{"key":"4833_CR52","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.coph.2018.05.010","volume":"41","author":"U Hafeez","year":"2018","unstructured":"Hafeez\u00a0U, Gan\u00a0HK, Scott\u00a0AM (2018) Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseases. Curr Opin Pharmacol 41:114\u2013121","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"4833_CR53","doi-asserted-by":"publisher","first-page":"e1117740","DOI":"10.1080\/2162402X.2015.1117740","volume":"5","author":"J Pol","year":"2016","unstructured":"Pol\u00a0J, Buqu\u00e9\u00a0A, Aranda\u00a0F et al (2016) Trial Watch-Oncolytic viruses and cancer therapy. Oncoimmunology 5(2):e1117740","journal-title":"Oncoimmunology"},{"issue":"36","key":"4833_CR54","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1200\/JCO.2011.38.0899","volume":"29","author":"SL Topalian","year":"2011","unstructured":"Topalian\u00a0SL, Weiner\u00a0GJ, Pardoll\u00a0DM (2011) Cancer immunotherapy comes of age. J\u00a0Clin Oncol 29(36):4828\u20134836","journal-title":"J Clin Oncol"},{"issue":"11\u201312","key":"4833_CR55","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00335-018-9756-5","volume":"29","author":"K Gowrishankar","year":"2018","unstructured":"Gowrishankar\u00a0K, Birtwistle\u00a0L, Micklethwaite\u00a0K (2018) Manipulating the tumor microenvironment by adoptive cell transfer of CAR T\u2011cells. Mamm Genome 29(11-12):739\u2013756","journal-title":"Mamm Genome"},{"issue":"3","key":"4833_CR56","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/cpt.394","volume":"100","author":"KA Marrone","year":"2016","unstructured":"Marrone\u00a0KA, Ying\u00a0W, Naidoo\u00a0J (2016) Immune-related adverse events from immune checkpoint inhibitors. Clin Pharmacol Ther 100(3):242\u2013251","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"4833_CR57","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1172\/JCI43490","volume":"120","author":"D Chinnasamy","year":"2010","unstructured":"Chinnasamy\u00a0D, Yu\u00a0Z, Theoret\u00a0MR et al (2010) Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice. J\u00a0Clin Invest 120(11):3953\u20133968","journal-title":"J Clin Invest"},{"issue":"8","key":"4833_CR58","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1136\/thx.54.8.707","volume":"54","author":"DR Thickett","year":"1999","unstructured":"Thickett\u00a0DR, Armstrong\u00a0L, Millar\u00a0AB (1999) Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions. Thorax 54(8):707\u2013710","journal-title":"Thorax"},{"issue":"2","key":"4833_CR59","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1091\/mbc.3.2.211","volume":"3","author":"B Berse","year":"1992","unstructured":"Berse\u00a0B, Brown\u00a0LF, Van de Water\u00a0L et\u00a0al (1992) Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors[J]. Mol Biol Cell 3(2):211\u2013220. https:\/\/doi.org\/10.1091\/mbc.3.2.211","journal-title":"Mol Biol Cell"},{"issue":"1","key":"4833_CR60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/0970-258X.243406","volume":"31","author":"R Vatsa","year":"2018","unstructured":"Vatsa\u00a0R, Kumar\u00a0L, Kumar\u00a0S, Roy\u00a0KK, Singh\u00a0N, Meena\u00a0J (2018) Frontline use of bevacizumab in ovarian cancer: Experience from India. Natl Med J India 31(1):15\u201318","journal-title":"Natl Med J India"},{"key":"4833_CR61","first-page":"2767","volume":"8","author":"D Chen","year":"2015","unstructured":"Chen\u00a0D, Zhang\u00a0Y, Shi\u00a0F et\u00a0al (2015) Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a\u00a0case report and literature review. Onco Targets Ther 8:2767\u20132770","journal-title":"Onco Targets Ther"},{"issue":"32","key":"4833_CR62","doi-asserted-by":"publisher","first-page":"52436","DOI":"10.18632\/oncotarget.9420","volume":"7","author":"D Chen","year":"2016","unstructured":"Chen\u00a0D, Zhang\u00a0Y, Shi\u00a0F et\u00a0al (2016) Intrapericardial bevacizumab safely and effectively treats malignant pericardial effusion in advanced cancer patients. Oncotarget 7(32):52436\u201352441","journal-title":"Oncotarget"},{"issue":"8","key":"4833_CR63","first-page":"483","volume":"80","author":"RM Del","year":"2016","unstructured":"Del\u00a0RM, Tsai\u00a0H, Dasanu\u00a0CA (2016) Prolonged survival in colon cancer with malignant pericardial effusion and pulmonary lymphangitic carcinomatosis: a case for monoclonal antibodies. Conn Med 80(8):483\u2013485","journal-title":"Conn Med"},{"key":"4833_CR64","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.gore.2016.01.006","volume":"16","author":"T Ueda","year":"2016","unstructured":"Ueda\u00a0T, Tsubamoto\u00a0H, Eguchi\u00a0A, Terada\u00a0T, Shibahara\u00a0H (2016) Bevacizumab helped resolve pericardial and pleural effusion that was associated with malignant ovarian clear cell carcinoma. Gynecol Oncol Rep 16:11\u201313","journal-title":"Gynecol Oncol Rep"},{"issue":"6","key":"4833_CR65","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3748\/wjg.v16.i6.740","volume":"16","author":"T Oida","year":"2010","unstructured":"Oida\u00a0T, Mimatsu\u00a0K, Kano\u00a0H et\u00a0al (2010) Pericardiocentesis with cisplatin for malignant pericardial effusion and tamponade. World J Gastroenterol 16(6):740\u2013744","journal-title":"World J Gastroenterol"},{"issue":"4","key":"4833_CR66","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nri3191","volume":"12","author":"NP Restifo","year":"2012","unstructured":"Restifo\u00a0NP, Dudley\u00a0ME, Rosenberg\u00a0SA (2012) Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 12(4):269\u2013281","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 2","key":"4833_CR67","doi-asserted-by":"publisher","first-page":"B61","DOI":"10.1016\/j.vaccine.2007.06.038","volume":"25","author":"VG Brichard","year":"2007","unstructured":"Brichard\u00a0VG, Lejeune\u00a0D (2007) GSK\u2019s antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development. Vaccine 25(Suppl 2):B61\u2013B71","journal-title":"Vaccine"},{"issue":"4","key":"4833_CR68","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ccr.2013.03.018","volume":"23","author":"B Engels","year":"2013","unstructured":"Engels\u00a0B, Engelhard\u00a0VH, Sidney\u00a0J et al (2013) Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity. Cancer Cell 23(4):516\u2013526","journal-title":"Cancer Cell"},{"issue":"24","key":"4833_CR69","doi-asserted-by":"publisher","first-page":"6758","DOI":"10.1158\/1078-0432.CCR-12-1177","volume":"18","author":"LG Radvanyi","year":"2012","unstructured":"Radvanyi\u00a0LG, Bernatchez\u00a0C, Zhang\u00a0M et al (2012) Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients. Clin Cancer Res 18(24):6758\u20136770","journal-title":"Clin Cancer Res"},{"issue":"10","key":"4833_CR70","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00262-005-0112-8","volume":"55","author":"U Toh","year":"2006","unstructured":"Toh\u00a0U, Fujii\u00a0T, Seki\u00a0N, Niiya\u00a0F, Shirouzu\u00a0K, Yamana\u00a0H (2006) Characterization of IL-2-activated TILs and their use in intrapericardial immunotherapy in malignant pericardial effusion. Cancer Immunol Immunother 55(10):1219\u20131227","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"4833_CR71","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00262-010-0860-y","volume":"59","author":"MW Helms","year":"2010","unstructured":"Helms\u00a0MW, Prescher\u00a0JA, Cao\u00a0YA, Schaffert\u00a0S, Contag\u00a0CH (2010) IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapy. Cancer Immunol Immunother 59(9):1325\u20131334","journal-title":"Cancer Immunol Immunother"},{"issue":"42","key":"4833_CR72","doi-asserted-by":"publisher","first-page":"e8310","DOI":"10.1097\/MD.0000000000008310","volume":"96","author":"J Hu","year":"2017","unstructured":"Hu\u00a0J, Hu\u00a0J, Liu\u00a0X, Hu\u00a0C, Li\u00a0M, Han\u00a0W (2017) Effect and safety of cytokine-induced killer (CIK) cell immunotherapy in patients with breast cancer: a meta-analysis. Medicine (Baltimore) 96(42):e8310","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"4833_CR73","first-page":"13146","volume":"8","author":"X Zhao","year":"2015","unstructured":"Zhao\u00a0X, Ji\u00a0CY, Liu\u00a0GQ et\u00a0al (2015) Immunomodulatory effect of DC\/CIK combined with chemotherapy in multiple myeloma and the clinical efficacy. Int J Clin Exp Pathol 8(10):13146\u201313155","journal-title":"Int J Clin Exp Pathol"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-019-4833-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-019-4833-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-019-4833-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T17:19:51Z","timestamp":1607361591000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-019-4833-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":73,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4833"],"URL":"https:\/\/doi.org\/10.1007\/s00059-019-4833-4","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,11]]},"assertion":[{"value":"17 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"J.\u00a0Zhang, Q.\u00a0Zhang, X.\u00a0Chen and N.\u00a0Zhang declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}